These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4281175)

  • 21. Effects of 7,12-dimethylbenz(a)anthracene on rat mammary epithelial cell macromolecules: a time study.
    Jabara AG; Minasian LC; Matthews JP
    J Natl Cancer Inst; 1975 Jul; 55(1):211-3. PubMed ID: 808636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dietary fat and dose level of 7,12-dimethylbenz(alpha)-anthracene on mammary tumor incidence in rats.
    Carroll KK; Khor HT
    Cancer Res; 1970 Aug; 30(8):2260-4. PubMed ID: 5459769
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of dimethylbenzanthracene and diethylstilbestrol on mammary adenocarcinoma formation in female ACI rats.
    Shellabarger CJ; McKnight B; Stone JP; Holtzman S
    Cancer Res; 1980 Jun; 40(6):1808-11. PubMed ID: 6768454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
    Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL
    Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
    Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T
    Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoplastic transformation of rat mammary cells exposed to 7,12-dimethylbenz[alpha]anthracene or N-nitrosomethylurea in cell culture.
    Richards J; Nandi S
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3836-40. PubMed ID: 99742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of human placental lactogen on growth of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1973 Jan; 11(1):131-7. PubMed ID: 4790832
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunoelectrophoretic analysis of DMBA-induced rat mammary tumours.
    Kellen JA; Lo AC; Kolos TO
    Oncology; 1971; 25(5):401-9. PubMed ID: 4111371
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 31. Suppression of 7,12-dimethylbenz(alpha) anthracene-induced breast carcinoma by coumarin in the rat.
    Feuer G; Kellen JA; Kovacs K
    Oncology; 1976; 33(1):35-9. PubMed ID: 824591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of vitamin B-15 on the induction of tumors of the mammary glands in rats by 9,10-dimethyl-1,2-benzanthracene].
    Beskrovnyĭ AM
    Vopr Onkol; 1971; 17(7):78-9. PubMed ID: 5137835
    [No Abstract]   [Full Text] [Related]  

  • 33. Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats.
    Kotsopoulos J; Sohn KJ; Martin R; Choi M; Renlund R; McKerlie C; Hwang SW; Medline A; Kim YI
    Carcinogenesis; 2003 May; 24(5):937-44. PubMed ID: 12771039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of experimental mammary carcinoma. Autologous intrasplenic ovarian transplant.
    Reichle FA; Gruenstein M; Reichle RM; Meranze DR; Rosemond GP; Shimkin MB
    Arch Surg; 1972 Feb; 104(2):206-8. PubMed ID: 5008916
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial fractionation of oestradiol-binding chromatin from dimethylbenzanthracene-induced rat mammary tumour.
    Pooley AS; King RJ
    J Endocrinol; 1971 Oct; 51(2):231-40. PubMed ID: 5121828
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis.
    Sinha DK; Dao TL
    J Natl Cancer Inst; 1980 Mar; 64(3):519-21. PubMed ID: 6766511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth of mammary glands from monodispersed cells and susceptibility to 7,12-dimethylbenz[alpha]anthracene.
    Sinha DK
    Cancer Lett; 1981 Mar; 12(1-2):111-19. PubMed ID: 6791816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by butylated hydroxytoluene and its oxidative metabolites of DMBA-induced mammary tumorigenesis and of mammary DMBA-DNA adduct formation in vivo in the female rat.
    Singletary KW; Nelshoppen JM; Scardefield S; Wallig M
    Food Chem Toxicol; 1992 Jun; 30(6):455-65. PubMed ID: 1500032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression by spironolactone of 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Kovacs K; Somogyi A
    Eur J Cancer (1965); 1970 Jun; 6(3):195-201. PubMed ID: 5477977
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of mammary carcinogenesis of dimethylbenzanthracene treated rats with a brominated triphenylethylene.
    Rudali G; Montes-Rendon A; Assa R
    Biomedicine; 1979 Sep; 31(5):142-6. PubMed ID: 116693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.